© 2019 The Sonder Group

So far, the first quarter of 2017 is looking good for NewCo life science platform companies in Boston.  908 Devices, a Boston based pioneer of small and elegantly systems for chemical and biomolecule analysis, announced a sales partnership with Thermo Fisher to sell their ZipChip™ as a front-end to Thermo’s mass spectrometry (MS) instruments. They followed that up by closing a $20M growth equity round in March. RedShift BioAnalytics, based in Burlington, MA, completed a Series C raise of $11M with strategic investments from Water...

Are you interested in monitoring the US venture capital funding in our sector?  Look no further than PwC’s MoneyTree report. The company offers a quarterly report that breaks down deals by quarter, stages and venture capital outlook for the life science sector. The most recent report, Q316, indicates that venture capitalists invested $2.5 billion in 156 life science companies during the third quarter which was down from $3.0 billion in 210 deals during the same quarter of 2015. The silver lining was that the average deal size increase...

The biotech job market continues to be strong – good news for companies and employees. Companies are hiring and for the first time in years, I am seeing candidates with multiple competitive offers. It is always important to find the best candidates for your teams, but in competitive markets finding “A” players and taking the time to find the right fit is imperative. There are a variety of hiring guides available but one that I highly recommend is, “Who, the A Method for Hiring” by Geoff Smart and Randy Street. It is an easy airplane r...

I had the pleasure of attending the two day GoldLab Symposium 2015 in Boulder, CO. The annual event seeks to bring together critical thinkers in bioscience, medicine, public policy, and the humanities to discuss complexities and barriers for improving health care. Its mission is to build an informed community of scientists, public influencers, and other stakeholders to bring light to the nation’s healthcare crisis and provide exciting concepts as potential solutions.

The symposium is the brain child of Larry Gold, Professor at The Univ...

Please reload

Categories
Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon